Please click the following link to review our commentary on Sentiment, Leverage, Is it Early 2018 Again or…? What would you say is the most interesting finding in the historical data noted below? The table identifies years in which the S&P 500 captures a 30% or greater return. The most interesting concept concerning the chart above, is found in the…
Sentiment, Leverage, Is it Early 2018 Again or…?
A financial market resource for the every-day investor and trader.
-
Global Financial Data: 200 Years of Market Concentration
Seth Golden, , Research Reports, 0
Two-Hundred Years of Market Concentration in the United States Dr. Bryan Taylor, Chief Economist, Global Financial Data Investors have...
-
Gamma Shift Continuation & Commodity Plays In Focus: J.P. Morgan Quant Team
Seth Golden, , Research Reports, 0
Volatility Review 19 February 2019 Equity Derivatives Strategy Bram Kaplan, CFA AC, Marko Kolanovic, PhD Positioning update, RTY and...
-
Morgan Stanley Goes Full Bull on Staples, Adds GOOGL To Focus Buy List
Seth Golden, , Research Reports, 0
Weekly Warm-up: More on The Mid Cycle Transition to Quality; Staples over Discretionary Last week we argued for a...
-
The Myths of Stocks For The Long Run-Part II: By Lance Roberts
Seth Golden, , Research Reports, 0
Written by Lance Roberts | Jun, 11, 2018 Crashes Matter A Lot In Part I – Buy and Hold can be...
-
Merrill Lynch: Triggers Defining New Equity Bull Market
Seth Golden, , Research Reports, 0
Macro Strategy—Fixed Income Positioning: Be Circumspect and Mind the Disconnect: For the past several months, risk assets including credit...
-
-
Morgan Stanley: Reaching Herd Immunity
Seth Golden, , Research Reports, 0
When can the US achieve broad vaccination of its population: Using the current rate of daily vaccinations (red line,...
-
Bed Bath & Beyond Q3 Results Find Gross Margins At All-Time Lows
Seth Golden, , Research Reports, 1
Since 2014, Bed Bath & Beyond has found itself in the precarious situation that has plagued many a brick...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00